(Q38027754)

27 August 2017

title

The role of innate immunity in HBV infection (English)

1 reference

27 August 2017

Qiuju Han

1

1 reference

27 August 2017

Cai Zhang

series ordinal

2

1 reference

27 August 2017

Jian Zhang

series ordinal

3

1 reference

27 August 2017

Zhigang Tian

series ordinal

4

1 reference

27 August 2017

publication date

20 July 2012

1 reference

Seminars in Immunopathology

27 August 2017

published in

1 reference

27 August 2017

volume

35

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

23-38

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-012-0331-y

27 August 2017

exact match

0 references

cites work

Innate and adaptive immune responses in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Kinetics of the immune response during HBV and HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Involvement of natural killer cells in PolyI:C-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Genomic analysis of the host response to hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Up on the tightrope: natural killer cell activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Immune tolerance split between hepatitis B virus precore and core proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Immune effectors required for hepatitis B virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Functions of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Epidemic of hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Liver NKT cells: an account of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Transcriptional and posttranscriptional control of hepatitis B virus gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The immune response during hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Inflammasome recognition of influenza virus is essential for adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Central roles of NLRs and inflammasomes in viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

From virus to inflammation: mechanisms of RIG-I-induced IL-1β production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Critical contribution of liver natural killer T cells to a murine model of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Importance of Kupffer cells for T-cell-dependent liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Recruitment of dendritic cells to pathological niches in inflamed liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Galactosamine-induced sensitization to the lethal effects of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Circulating mitochondrial DAMPs cause inflammatory responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

A T cell-dependent experimental liver injury in mice inducible by concanavalin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Critical role of NK cells rather than V alpha 14(+)NKT cells in lipopolysaccharide-induced lethal shock in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Roles of CD14 in LPS-induced liver injury and lethality in mice pretreated with Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

PD-1 on dendritic cells impedes innate immunity against bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0331-Y

Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B

21 January 2018

1 reference

12 December 2020

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

12 December 2020

Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B

1 reference

12 December 2020

Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta

1 reference

12 December 2020

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

1 reference

12 December 2020

LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor

1 reference

12 December 2020

Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury

1 reference

12 December 2020

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

12 December 2020

Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation

1 reference

12 December 2020

HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients

1 reference

12 December 2020

[Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients]

1 reference

12 December 2020

Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A

1 reference

12 December 2020

Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism

1 reference

12 December 2020

MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis

1 reference

12 December 2020

The roles of innate immune cells in liver injury and regeneration.

1 reference

12 December 2020

The role of the liver in the response to LPS: experimental and clinical findings

1 reference

12 December 2020

Involvement of TRAIL and its receptors in viral hepatitis

1 reference

12 December 2020

Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure

1 reference

12 December 2020

Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.

1 reference

12 December 2020

Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism

1 reference

12 December 2020

Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases

1 reference

12 December 2020

Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice

1 reference

12 December 2020

Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2)

1 reference

12 December 2020

The hepatocyte as a microbial product-responsive cell

1 reference

12 December 2020

Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

1 reference

12 December 2020

Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis

1 reference

12 December 2020

Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection

1 reference

12 December 2020

Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV

1 reference

12 December 2020

Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice

1 reference

12 December 2020

10.1007/S00281-012-0331-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1016842966

0 references

1 reference